Helus Pharma Inc. (HELP)
Helus Pharma is a clinical-stage pharmaceutical company developing proprietary serotonergic agonists for mental health conditions. Its pipeline includes HLP003, in Phase 3 development for adjunctive treatment of major depressive disorder, and HLP004, in Phase 2 development for generalized anxiety disorder.
Sector: Pharmaceutical Preparations
Industry: Medical - Pharmaceuticals
Helus Pharma Inc. Common Stock
NASDAQ:HELPHealthcare · Medical - Pharmaceuticals
AHAfter hours+0.64%$9.43
Prev close$8.96+4.58%Close$9.37+0.64%Now$9.43
Close$9.37+4.58%
Mkt Cap$684.66M
Float50.07M
O/S73.07M
VOL1.6M sh
$ Vol$14.93M
RVOL1.04×
Inst Own42.5%
Dilution
Financials Summary
Revenue-$44.68M
Net Income-$147.05M
Total Assets$251.98M
Free Cash Flow-$133.79M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$232.24M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in HELP's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$251.98M
Liabilities$19.44M
Accounts Receivable$5.03M
Accounts Payable$0
Inventory$0
PP&E (Net)$196K
Goodwill$36.34M
Intangible Assets$30.32M
Income Statement
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-07-31 | 2018-07-31 | 2017-07-31 |
| Revenue | -$44.68M | $472K | $0 | $251K | $168K | $864K | $0 | $0 | $0 | $0 |
| YoY Growth | -9561.6% | - | - | 49.6% | -80.6% | - | - | - | - | - |
| Cost of Revenue | $119K | $472K | $0 | $251K | $168K | $1.18M | $0 | $0 | $0 | $0 |
| Gross Profit | -$44.8M | $0 | $0 | $0 | $0 | -$311K | $0 | $0 | $0 | $0 |
| Gross Margin | 100.3% | - | - | - | - | -36.0% | - | - | - | - |
| Research and Development | $86.04M | $54.91M | $32.36M | $25.49M | $17.59M | $3.3M | $322K | $0 | $0 | $0 |
| Selling, General, and Administrative | $56M | $88.24M | $46.47M | $26.03M | $46.25M | $27.42M | $1.63M | $81K | $190K | $127K |
| Other | -$45.16M | $0 | $0 | $0 | $0 | $0 | -$10K | $0 | $0 | $0 |
| Total Operating Expenses | $96.87M | $143.15M | $78.84M | $51.52M | $63.84M | $30.72M | $1.94M | $81K | $190K | $127K |
| Operating Income (EBIT) | -$141.68M | -$143.15M | -$78.84M | -$51.52M | -$63.84M | -$31.04M | -$1.95M | -$81K | -$190K | -$127K |
| Operating Margin | 317.1% | -30310.4% | - | -20523.9% | -38053.2% | -3592.0% | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $10K | $0 | $0 | $0 | $0 |
| Interest Income | $5.07M | $8.29M | $619K | $603K | $241K | $60K | $0 | $0 | $0 | $0 |
| Other Income (Expense) | $83.99M | $29.54M | $756K | $3.78M | -$3.96M | -$1.19M | $10K | -$20K | -$31K | $4 |
| Income Before Tax (EBT) | -$57.69M | -$113.61M | -$78.08M | -$47.74M | -$67.8M | -$32.22M | -$1.94M | -$101K | -$221K | -$127K |
| Income Tax Expense | $89.37M | -$472K | $0 | -$251K | -$168K | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$147.05M | -$113.14M | -$78.08M | -$47.49M | -$67.63M | -$32.22M | -$1.94M | -$101K | -$221K | -$127K |
| Net Income Margin | 329.1% | -23956.0% | - | -18919.2% | -40314.1% | -3729.2% | - | - | - | - |
| Supplementary Data | ||||||||||
| EPS | -4.23 | -5.59 | -3.91 | -9.73 | -15.36 | -12.24 | -1.48 | -0.28 | -0.69 | -0.35 |
| Diluted EPS | -4.23 | -5.59 | -9.41 | -9.74 | -15.36 | -12.24 | -1.82 | -0.28 | -0.69 | -0.35 |
| Weighted Average OS | 34.80M | 20.22M | 20.00M | 4.88M | 4.40M | 2.63M | 1.06M | 365,428 | 320,151 | 360,526 |
| EBITDA | -$141.56M | -$142.67M | -$78.41M | -$51.27M | -$63.67M | -$30.99M | -$400 | -$81K | -$221K | -$127K |
| EBITDA Margin | 316.8% | -30210.4% | - | -20423.9% | -37953.0% | -3586.3% | - | - | - | - |
Balance Sheet
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-07-31 | 2018-07-31 | 2017-07-31 |
| Assets | ||||||||||
| Current Assets | ||||||||||
| Cash and Cash Equivalents | $157.78M | $135.02M | $208.99M | $16.63M | $53.64M | $64.03M | $1.54M | $314K | $433K | $433K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $157.78M | $135.02M | $208.99M | $16.63M | $53.64M | $64.03M | $1.54M | $314K | $433K | $433K |
| Accounts Receivable | $5.03M | $5.88M | $4.48M | $3.05M | $2.1M | $1.33M | $74K | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $2.91M | $2.18M | $1.77M | $1.34M | $0 | $0 | $4K | $3K | $263 |
| Total Current Assets | $185.11M | $165.97M | $218.54M | $23.18M | $58.35M | $66.48M | $1.64M | $318K | $436K | $433K |
| Long-Term Assets | ||||||||||
| Property, Plant & Equipment Net | $196K | $141K | $547K | $450K | $491K | $557K | $0 | $0 | $0 | $0 |
| Goodwill | $36.34M | $51.49M | $47.48M | $24.79M | $22.89M | $23.37M | $0 | $0 | $0 | $0 |
| Intangible Assets | $30.32M | $41.02M | $35.47M | $5.47M | $2.08M | $1.7M | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $242K | $0 | $71K | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $90K | $20K | $10K |
| Total Long-Term Assets | $66.86M | $92.65M | $83.49M | $30.71M | $25.71M | $25.63M | $71K | $90K | $20K | $10K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $251.98M | $258.62M | $302.02M | $53.9M | $84.06M | $92.11M | $1.71M | $408K | $456K | $443K |
| Liabilities | ||||||||||
| Current Liabilities | ||||||||||
| Accounts Payable | $0 | $21.42M | $9.8M | $5.66M | $5.26M | $2.79M | $0 | $0 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $19.44M | $0 | $9.8M | $0 | $0 | $0 | $263K | $14K | $16K | $150K |
| Total Current Liabilities | $19.44M | $21.42M | $10.1M | $5.66M | $7.91M | $4.9M | $263K | $14K | $16K | $150K |
| Long-Term Liabilities | ||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $1.09M | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $1.09M | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $19.44M | $21.42M | $10.1M | $5.66M | $7.91M | $5.99M | $263K | $14K | $16K | $150K |
| Stockholders' Equity | ||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $493.72M | $464.36M | $443.88M | $158.16M | $141.45M | $100.68M | $2.19M | $721K | $666K | $420K |
| Retained Earnings | -$390.82M | -$339.37M | -$226.23M | -$148.15M | -$100.66M | -$33.03M | -$810K | -$449K | -$348K | -$127K |
| Comprehensive Income & Other | $8.08M | -$7.23M | -$2.29M | -$2.04M | -$366K | $24K | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $129.34M | $112.2M | $74.28M | $38.22M | $35.37M | $18.47M | $71K | $122K | $122K | $0 |
| Total Equity | $232.24M | $237.2M | $291.93M | $48.23M | $76.16M | $86.12M | $1.45M | $395K | $440K | $293K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $251.68M | $258.62M | $302.02M | $53.9M | $84.06M | $92.11M | $1.71M | $408K | $456K | $443K |
| Supplementary Data | ||||||||||
| Total Debt | $0 | $0 | $291K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Debt | -$157.78M | -$135.02M | -$208.7M | -$16.63M | -$53.64M | -$64.03M | -$1.54M | -$314K | -$433K | -$433K |
Cash Flow Statement
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-07-31 | 2018-07-31 | 2017-07-31 |
| Operating Activities | ||||||||||
| Net Income | -$147.05M | -$113.14M | -$78.08M | -$47.49M | -$67.63M | -$32.22M | -$2K | -$101K | -$221K | -$127K |
| Depreciation & Amortization | $120K | $472K | $424K | $251K | $168K | $49K | $1.95M | $0 | $0 | $0 |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $0 | $42.87M | $13.89M | $4.69M | $18.03M | $11.55M | $154 | $0 | $0 | $0 |
| Changes in Working Capital: | ||||||||||
| Accounts Receivable | -$928K | -$1.41M | -$1.09M | -$948K | -$773K | -$1.49M | -$178 | $0 | -$3K | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | -$511K | $0 | $0 | $0 | $0 |
| Accounts Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Working Capital | -$321K | -$8.38M | -$3.94M | -$489K | $986K | $729K | -$48 | -$3K | -$114K | $130K |
| Total Working Capital Change | -$1.25M | -$9.79M | -$5.03M | -$1.44M | $213K | -$1.27M | -$226 | -$3K | -$117K | $130K |
| Other Non-Cash Items | $15.76M | -$21.71M | -$111K | -$3.44M | $4.01M | $2.86M | -$1.95M | $20K | $101K | $0 |
| Net Cash from Operating | -$132.42M | -$101.3M | -$68.91M | -$47.43M | -$45.21M | -$19.03M | -$1K | -$84K | -$237K | $3K |
| Investing Activities | ||||||||||
| Capital Expenditures | -$1.36M | -$1.97M | -$710K | -$142K | -$105K | -$135K | $0 | -$35K | -$10K | -$10K |
| Acquisitions | $10K | $0 | $7.63M | $0 | $0 | -$958K | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | -$250K | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | -$3.17M | -$415K | -$96K | -$170 | $0 | $0 | $0 |
| Net Cash from Investing | -$1.35M | -$1.97M | $6.92M | -$3.31M | -$770K | -$1.19M | -$170 | -$35K | -$10K | -$10K |
| Financing Activities | ||||||||||
| Debt Repaid | -$24.19M | $290K | $149K | - | - | - | - | - | - | - |
| Common Stock Issuance | $172.78M | $20.49M | $254.66M | $13.56M | $35.78M | $76.24M | $0 | $0 | $267K | $440K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 | $0 | $0 | $6.49M | $5K | $0 | -$20K | $448 |
| Net Cash from Financing | $196.97M | $20.2M | $254.51M | $13.56M | $35.78M | $82.72M | $5K | $0 | $247K | $440K |
| Forex Effect | $758K | $9.1M | -$162K | $168K | -$185K | -$28K | $0 | $0 | $0 | $0 |
| Net Change in Cash | $63.96M | -$73.97M | $192.36M | -$37.01M | -$10.38M | $62.48M | $4K | -$119K | $294 | $433K |
| Supplementary Data | ||||||||||
| Operating Cash Flow | -$132.42M | -$101.3M | -$68.91M | -$47.43M | -$45.21M | -$19.03M | -$1K | -$84K | -$237K | $3K |
| Capital Expenditure | -$1.36M | -$1.97M | -$710K | -$3.31M | -$520K | -$231K | $0 | -$35K | -$10K | -$10K |
| Free Cash Flow | -$133.79M | -$103.27M | -$69.62M | -$50.74M | -$45.73M | -$19.26M | -$1K | -$119K | -$247K | -$7K |
| Cash at Beginning | $93.82M | $208.99M | $16.63M | $53.64M | $64.03M | $1.54M | $3.7M | $433K | $433K | $0 |
| Cash at End | $157.78M | $135.02M | $208.99M | $16.63M | $53.64M | $64.03M | $3.71M | $314K | $433K | $433K |